Investigation and inquest
On 3rd January 2018 I commenced an investigation into the death of Michael John Drewell, aged 57. The investigation concluded at the end of the inquest on 22nd August 2018. The conclusion of the inquest was that Mr Drewell died of a pulmonary thromboembolism.
Circumstances of the death
On the 16th November 2017 Mr Drewell fell off his bike whilst travelling to work. He attended at Leeds General Infirmary and was diagnosed with a displaced ultra capsular fracture of his right hip. He subsequently underwent surgery and his hip fracture was fixed with cannulated screws.
On the 17th November 2017 his treating Consultant advised that he take Tinzaparin for six weeks to reduce the risk of Deep Vein Thrombosis.
He was discharged from hospital on the 22nd November 2017 and was provided with a four week prescription for Tinzaparin. That prescription was given in accordance with National Guidelines but was not for the period of time, (ie six weeks), as advised by the Consultant. The prescription ended two days prior to his death.
It is not possible to say whether the ending of the prescription more than minimally contributed to his death.
On the 22nd December 2017 he suffered a cardiac arrest at home. Paramedics attended but were unable to resuscitate him. He was taken to the Leeds General Infirmary and death was pronounced at 2355 hours that day.
He died of a pulmonary thromboembolism which was likely a complication of his earlier hip surgery.
Coroner’s concerns
The treating Consultant advised that Mr Drewell, because of his height and weight, be given anti-coagulant Tinzaparin for six weeks rather than four weeks as was usual. He recorded his advice on the handwritten records at hospital following a ward round the day after surgery.
When the Junior Doctor came to prescribe Tinzaparin several days later he likely did not consult the handwritten notes and only prescribed four weeks Tinzaparin immediately before Mr Drewell’s discharge from hospital.
Evidence was heard that Junior Doctors would not be expected to consult the handwritten notes when prescribing drugs in accordance with NICE Guidelines.
It is of concern that the advice of a Senior Clinician was not followed and, further, that his advice was not placed upon the electronic notes.